Literature DB >> 9250363

Phosphorylation site substrate specificity determinants for the Pim-1 protooncogene-encoded protein kinase.

C K Palaty1, I Clark-Lewis, D Leung, S L Pelech.   

Abstract

Pim-1 is an oncogene-encoded serine-threonine kinase that is expressed primarily in cells of the hematopoietic system and germ line. The full-length coding regions of both human and Xenopus laevis Pim-1 were expressed as recombinant bacterial fusion proteins that autophosphorylated in vitro and exhibited phosphotransferase activity towards various exogenous substrates. The consensus sequence for phosphorylation by Pim-1 was defined by stepwise replacement of the amino acids in peptide substrate analogues based on the carboxyl-terminal segment of human ribosomal protein S6 (residues 229-249). The optimal substrate peptide for Pim-1 was determined to be Lys/Arg-Lys/Arg-Arg-Lys/Arg-Leu-Ser/Thr-X, where X is an amino acid residue with a small side chain. These results were confirmed using X. laevis Pim-1 expressed in COS cells. These findings could permit the identification of physiological substrates of Pim-1 and predict the location of phosphorylation sites within these proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250363

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  13 in total

1.  Ischemia-reperfusion injury up-regulates Pim-3 gene expression in myocardial tissue.

Authors:  Libing Zhao; Yinfang Wang; Xinwen Min; Handong Yang; Peng Zhang; Qiutang Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

Review 2.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

Review 3.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.

Authors:  Laurent Brault; Christelle Gasser; Franz Bracher; Kilian Huber; Stefan Knapp; Jürg Schwaller
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

4.  PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.

Authors:  Xiu Feng Hu; Jie Li; Scott Vandervalk; Zeping Wang; Nancy S Magnuson; Pei Xiang Xing
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

5.  Elevated levels of oncogenic protein kinase Pim-1 induce the p53 pathway in cultured cells and correlate with increased Mdm2 in mantle cell lymphoma.

Authors:  Carol Hogan; Caroline Hutchison; Lynnette Marcar; Diane Milne; Mark Saville; John Goodlad; Neil Kernohan; David Meek
Journal:  J Biol Chem       Date:  2008-05-08       Impact factor: 5.157

6.  EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.

Authors:  Shuvomoy Banerjee; Jie Lu; Qiliang Cai; Zhiguo Sun; Hem Chandra Jha; Erle S Robertson
Journal:  PLoS Pathog       Date:  2014-08-14       Impact factor: 6.823

7.  Rational Redesign of a Functional Protein Kinase-Substrate Interaction.

Authors:  Catherine Chen; Wutigri Nimlamool; Chad J Miller; Hua Jane Lou; Benjamin E Turk
Journal:  ACS Chem Biol       Date:  2017-03-29       Impact factor: 5.100

8.  Loss of PIM1 correlates with progression and prognosis of salivary adenoid cystic carcinoma (SACC).

Authors:  Jiajie Xu; Xin Zhu; Qingling Li; Chao Chen; Zhenying Guo; Zhuo Tan; Chuanming Zheng; Minghua Ge
Journal:  Cancer Cell Int       Date:  2018-02-20       Impact factor: 5.722

9.  Proviral integration site for Moloney murine leukemia virus (PIM) kinases promote human T helper 1 cell differentiation.

Authors:  Johanna Tahvanainen; Minna K Kyläniemi; Kartiek Kanduri; Bhawna Gupta; Hanna Lähteenmäki; Teemu Kallonen; Anna Rajavuori; Omid Rasool; Päivi J Koskinen; Kanury V S Rao; Harri Lähdesmäki; Riitta Lahesmaa
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

10.  Pim-1 kinase phosphorylates and stabilizes 130 kDa FLT3 and promotes aberrant STAT5 signaling in acute myeloid leukemia with FLT3 internal tandem duplication.

Authors:  Karthika Natarajan; Yingqiu Xie; Mehmet Burcu; Douglas E Linn; Yun Qiu; Maria R Baer
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.